Betty Villafuerte is an Endocrinology/Metabolic physician affiliated with University of Louisville. OpenAlex indexes 17 publications with 583 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Breckenridge St Ste 200
Owensboro, KY 423030876
Telephone
270-691-8040Provider last certified this registry record 16 Jul 2020.
Industry payments
45 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202518 payments
- Amgen Inc.Program year20257 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
58.9%Insulin Analog15.3%Lantus Solostar42%Basaglar Kwikpen U-10012%Humalog Kwikpen U-1009%Insulin Lispro Kwikpen U-1008%Novolog Flexpen6%Levemir Flexpen4%Tresiba Flextouch U-1004%Tresiba Flextouch U-2003%Insulin Lispro3%Fiasp Flextouch2%Lantus2%Admelog Solostar2%Humalog2%Soliqua 100-331%Part D<11 patientsGLP-1 receptor agonist11%Ozempic78%Mounjaro16%Rybelsus3%Trulicity3%Part D<11 patients+ 13 more classes in this area
Hormonal (systemic)
21.8%l-Thyroxine17.9%Levothyroxine Sodium89%Synthroid10%Levoxyl1%Part D<11 patientsl-Triiodothyronine2.4%Liothyronine Sodium100%Part D≥34 patients+ 3 more classes in this area
Cardiovascular
9.2%Angiotensin receptor blocker (ARB)2.3%Losartan Potassium66%Losartan-Hydrochlorothiazide25%Irbesartan9%Part D<11 patientsStatin1.6%Rosuvastatin Calcium30%Lovastatin28%Atorvastatin Calcium23%Pravastatin Sodium19%Part D<11 patients+ 8 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2005–2008 per NIH RePORTER. The latest:
- Insulin Control of Gene Transcription Through Sensitin
University of Louisville
FY2008$245,872R01DK067413 - Insulin Control of Gene Transcription Through Sensitin
University of Louisville
FY2007$250,889R01DK067413 - Insulin Control of Gene Transcription Through Sensitin
University of Louisville
FY2006$258,382R01DK067413
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Over-expression of insulin-response element binding protein-1 (IRE-BP1) in mouse pancreatic islets increases expression of RACK1 and TCTP: Beta cell markers of high glucose sensitivity
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
2016
Similar KOLs
Other experts from the same institution or the same specialty.
James Franciosi, MD
University of Louisville
Matthew Cave, MD
University of Louisville
David Tollerud, MD
University of Louisville
Goetz Kloecker, MD
University of Louisville
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”